Identification of novel molecular markers which correlate with HPV-induced tumor progression

Oncogene

Volumn 16, Issue 19, 1998, Pages 2447-2458

  Nees, Matthias ^a,b   Van Wijngaarden, Erwin ^a,c   Bakos, Evi ^a   Schneider, Achim ^d   Dürst, Matthias ^a,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cervical cancer; Differential display; HPV (human papillomavirus); Prognostic markers; Tumor progression

Indexed keywords

CYTOSKELETON PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; SCLEROPROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; BIOPSY; CANCER; CONTROLLED STUDY; CYTOSKELETON; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATINOCYTE; PAPOVAVIRUS; PRECANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TUMOR GROWTH; UTERINE CERVIX EPITHELIUM; VIRUS CARCINOGENESIS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 0032516240     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201785     Document Type: Article

References (59)

1. Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Hoglund M, Forster A, Rabbitts TH, Ron D, Mandahl N and Mitelman F. (1996). Genomics, 37, 1-8.
2. Barr FG. (1997). Curr. Top. Microbiol. Immunol., 220, 113-129.
3. Bauer D, Warthoe P, Rohde M and Strauss M. (1994). PCR Methods Appl., 4, 97-108.
4. Berditchevski F, Tolias KF, Wong K, Carpenter CL and Hemler ME. (1997). J. Biol. Chem., 272, 2595-2598.
5. Berditchevski F, Zutter MM and Hemler ME. (1996). Mol. Biol. Cell., 7, 193-207.
6. Berthod F, Germain L, Guignard R, Lethias C, Garrone R, Damour O, van der Rest M and Auger FA. (1997). J. Invest. Dermatol., 108, 737-742.
7. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A, et al. (1995). Oncogene, 10, 1511-1519.
8. Calvin C, Neubauer G, Mann M and Lamond AI. (1995). RNA, 1, 724-733.
9. Chen TM, Pecoraro G and Defendi V. (1993). Cancer Res, 53, 1167-1171.
10. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
11. Cuzick J, Sasieni P and Singer A. (1996). Eur. J. Cancer 32A, 836-841.
12. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST and Guillebaud J. (1995). Lancet, 345, 1533-1536.
13. Despres N, Talbot G, Plouffe B, Boire G and Menard HA. (1995). J. Clin. Invest., 95, 1891-1896.
14. Dürst M, Seagon S, Wanschura S, zur Hausen H and Bullerdiek J. (1995). Cancer Genet. Cytogenet., 85, 105-112.
15. Dürst M, Gallahan D, Jay G and Rhim JS. (1989). Virology, 173, 767-771.
16. Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE and Gissmann L. (1987). Oncogene, 1, 251-256.
17. Feinberg AP and Vogelstein B. (1983). Anal. Biochem., 132, 6-13.
18. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher III FJ, Emanuel BS, Rovera G and Barr FG. (1993). Nat. Genet., 5, 230-235.
19. Ge Q, Nilasena DS, O'Brien CA, Frank MB and Targoff IN. (1995). J. Clin. Invest., 96, 1730-1737.
20. Gerecke DR, Olson PF, Koch M, Knoll JH, Taylor R, Hudson DE, Champliaud MF, Olsen BR and Burgeson RE. (1997). Genomics, 41, 236-242.
21. Gress TM, Muller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Buchler M, Adler G and Lehrach H. (1996). Oncogene, 13, 1819-1830.
22. Hedblom E and Kirkness EF. (1997). J. Biol. Chem., 272, 15346-15350.
23. Herrington CS, Evans MF, Charnock FM, Gray W and O'D McGee J. (1996). J. Clin. Pathol., 49, 493-496.
24. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G and Ried T. (1996). Proc. Natl. Acad. Sci. USA, 93, 479-484.
25. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al. (1994). J. Infect. Dis., 169, 235-240.
26. Hoppe-Seyler F and Butz K. (1995). J. Mol. Med., 73, 529-538.
27. Kiviat NB, Koutsky LA, Critchlow CW, Lorincz AT, Cullen AP, Brockway J and Holmes KK. (1992). Int. J. Gynecol. Pathol., 11, 197-203.
28. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D and Kiviat NB. (1992). N. Engl. J. Med., 327, 1272-1278.
29. Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kiev NA, et al. (1995). Oncogene, 10, 1521-1528.
30. Liang P, Bauer D, Averboukh L, Warthoe P, Rohrwild M, Muller H, Strauss M and Pardee AB. (1995). Methods Enzymol., 254, 304-321.
31. Liang P, Averboukh L and Pardee AB. (1993). Nucleic Acids Res., 21, 3269-3275
32. Liang P, Averboukh L, Keyomarsi K, Sager R and Pardee AB. (1992). Cancer Res., 52, 6966-6968.
33. Liang P and Pardee AB. (1992). Science, 257, 967-971.
34. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C and Singer A. (1996). Int. J. Cancer, 69, 364-368.
35. Mannion BA, Berditchevski F, Kraeft SK, Chen LB and Hemler ME. (1996). J. Immunol., 157, 2039-2047.
36. Muir C, Waterhause J, Mack T, Powell J and Whelan S. (eds), (1987). Cancer incidence in five continents. IARC; Lyon
37. Nindl I, Gissmann L, Fisher SG, Bribiesca LB, Berumen J and Muller M. (1996). J. Virol. Methods, 62, 81-85.
38. Pirisi L, Yasumoto S, Feller M, Doniger J and DiPaolo JA. (1987). J. Virol., 61, 1061-1066.
39. Ponten J, Adami HO, Friberg LG, Gustafsson L, Miller AB, Parkin M, Sparen P and Trichopoulos D. (1995). Int. J. Cancer, 63, 317.
40. Reid R, Greenberg MD, Lorincz A, Jenson AB, Laverty CR, Husain M, Daoud Y, Zado B, White T, Cantor D, et al. (1991). Am. J. Obstet. Gynecol., 164, 1461-1469.
41. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H and Boucheix C. (1996). Eur. J. Immunol., 26, 2657-2665.
42. Sager R, Sheng S, Anisowicz A, Sotiropoulou G, Zou Z, Stenman G, Swisshelm G, Chen Z, Hendrix MJ, Pemberton P, et al. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 537-546.
43. Sager R. (1997). Proc. Natl. Acad. Sci. USA, 94, 952-955.
44. Salamino F, Sparatore B, Melloni E, Michetti M, Viotti PL, Pontremoli S and Carafoli E. (1994). Cell Calcium, 15, 28-35.
45. Scheidler S, Fredericks WJ, Rauscher III FJ, Barr FG and Vogt PK. (1996). Proc. Natl. Acad. Sci. USA, 93, 9805-9809.
46. Schiffman MH. (1992). J. Natl. Cancer Inst., 84, 394-398.
47. Schlegel R, Phelps WC, Zhang YL and Barbosa M. (1988). EMBO J., 7, 3181-3187.
48. Schneider A, Zahm DM, Kirchmayr R and Schneider VL. (1996). Am. J. Obstet. Gynecol., 174, 1534-1541.
49. Seagon S and Dürst M. (1994). Cancer Res., 54, 5593-5598.
50. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M and Genth E. (1995). Arthritis Rheum., 38, 1389-1399.
51. Takagi S, Fujikawa K, Imai T, Fukuhara N, Fukudome K, Minegishi M, Tsuchiya S, Konno T, Hinuma Y and Yoshie O. (1995). Int. J. Cancer, 61, 706-715.
52. Tsutsumi K, Belaguli N, Qi S, Michalak TI, Gulliver WP, Pater A and Pater MM. (1992). Am. J. Pathol., 140, 255-261.
53. Williams JG, Kubelik AR, Livak KJ, Rafalski JA and Tingey SV. (1990). Nucleic Acids Res., 18, 6531-6535.
54. Woodworth CD, Doniger J and DiPaolo JA. (1989). J. Virol., 57, 572-577.
55. Woodworth CD, Bowden PE, Doniger J, Pirisi L, Barnes W, Lancaster WD and DiPaolo JA. (1988). Cancer Res., 48, 4620-4628.
56. Wright MD and Tomlinson MG. (1994). Immunol. Today, 15, 588-594.
57. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, Holmes KK and Galloway DA. (1995). J. Infect. Dis., 172, 747-755.
58. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B and Kinzler KW. (1997). Science, 276, 1268-1272.
59. Zinszner H, Immanuel D, Yin Y, Liang FX and Ron D. (1997). Oncogene, 14, 451-461.